During HIV type-1 (HIV-1), hepatitis C virus (HCV), and hepatitis B virus (HBV)
infections, altered
iron balance correlates with morbidity. The liver-produced
hormone hepcidin dictates systemic
iron homeostasis. We measured
hepcidin,
iron parameters,
cytokines, and inflammatory markers in three cohorts: plasma donors who developed acute HIV-1, HBV, or HCV
viremia during the course of donations; HIV-1-positive individuals progressing from early to
chronic infection; and chronically HIV-1-infected individuals (receiving antiretroviral
therapy or untreated).
Hepcidin increased and plasma
iron decreased during acute HIV-1
infection, as
viremia was initially detected. In patients transitioning from early to chronic HIV-1
infection,
hepcidin in the first 60 d of
infection positively correlated with the later plasma viral load set-point.
Hepcidin remained elevated in individuals with untreated chronic HIV-1
infection and in subjects on ART. In contrast to HIV-1, there was no evidence of
hepcidin up-regulation or hypoferremia during the primary viremic phases of HCV or HBV
infection; serum
iron marginally increased during acute HBV
infection. In conclusion,
hepcidin induction is part of the pathogenically important systemic inflammatory cascade triggered during HIV-1
infection and may contribute to the establishment and maintenance of viral set-point, which is a strong predictor of progression to
AIDS and death. However, distinct patterns of
hepcidin and
iron regulation occur during different
viral infections that have particular tissue tropisms and elicit different systemic inflammatory responses. The hypoferremia of acute
infection is therefore a pathogen-specific, not universal, phenomenon.